Articles tagged with Multiple Sclerosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Ocrelizumab has been shown to significantly reduce new attacks in patients with relapsing MS, slow symptom progression in primary progressive MS, and decrease brain lesions. The drug also demonstrated lower rates of disability progression and fewer infusion-related reactions compared to placebo.
A study of over 6.5 million Ontario residents found that those living within 50 meters of high-traffic roads had a seven percent higher likelihood of developing dementia compared to those further away. The risk increased with proximity, but not for Parkinson's disease or multiple sclerosis.
A study of 6.6 million people found that those living within 50 meters of a major road had a small increased risk of developing dementia, with up to 7-11% cases potentially attributed to traffic exposure. The study also found no link between traffic exposure and Parkinson's disease or multiple sclerosis.
Researchers have made significant strides in treating primary progressive multiple sclerosis (PPMS) with ocrelizumab, a medication that targets immune cells contributing to the disease. The study, led by UTHealth's Jerry Wolinsky, shows substantial improvement in slowing disability progression and reducing new lesion formation.
Assistant Professor Leah Shriver aims to find new ways to promote nervous system regeneration and prevent destruction of brain cells in multiple sclerosis patients. She plans to study the cuprizone intoxication model to understand mechanisms contributing to oligodendrocyte and myelin loss.
Professor Ari Waisman receives prestigious Sobek Prize for groundbreaking multiple sclerosis research, enabling deeper insight into inflammatory cell role and regulation in the brain.
Research finds that high levels of free haemoglobin in the blood are associated with increased brain shrinkage in patients with secondary progressive multiple sclerosis. The study suggests that treatments targeting haemoglobin levels, rather than iron, may be a more effective approach to slowing disease progression.
Researchers have shown that macrocyclic MRI contrast agents may reduce the risk of gadolinium brain deposition, a concern for patients with multiple sclerosis. Macrocyclic agents were found to minimize deposits in the cerebellum, whereas linear agents posed a higher risk.
A recent study found that newborns with low vitamin D levels were more likely to develop multiple sclerosis (MS) later in life. The study analyzed data from over 500 Danish children born between 1981 and 2012, comparing their vitamin D levels to those of similar children without MS.
Researchers discovered a new signal path in the RAS that influences immune cells, specifically phagocytes, which play a key role in MS development. The Mas receptor's influence on macrophages could provide an anti-inflammatory treatment option for chronic inflammatory diseases.
A UTSA professor has developed an underwater virtual reality game that helps relieve symptoms of multiple sclerosis. The 'Shark Punch' game uses smart phones and dive masks to create a immersive experience, while also providing a form of aquatic therapy.
Researchers have found significant differences in men and women's brain function, with some genetic variants influencing susceptibility to multiple sclerosis. The study suggests a personalized strategy for prevention and treatment, taking into account gender-specific contributions.
Researchers from Duke University have identified two specific receptors, CXCR2 and LTBR, that play a key role in the development of drug-resistant multiple sclerosis. The study found that targeting these receptors may lead to successful treatment for patients who do not respond to interferon-beta treatment.
A large international study found that living in northerly climes is linked to an earlier age of starting MS symptoms. The study analyzed data from over 22,000 patients and found that each 10° increase in latitude was associated with a 10-month earlier onset.
Researchers have identified 200 genetic loci linked to multiple sclerosis, a disease where the immune system attacks the brain and spine. The study, which analyzed over 110,000 samples, highlights the complex interplay of different immune cells in MS susceptibility.
Researchers found that alemtuzumab improved disability scores by at least one point in nearly 28% of participants, compared to 15% of those receiving interferon. The treatment also showed significant improvements in thinking skills and mobility without tremor or clumsy movements.
Researchers discovered a molecule, VGF nerve growth factor, triggered by running can help repair damaged nerve insulation in the brain. This finding could pave the way for new treatments for multiple sclerosis and other neurodegenerative disorders.
University of Groningen scientists discovered that tumor necrosis factor receptor 2 (TNFR2) is essential for preventing neuronal death in neurodegenerative diseases like multiple sclerosis and Alzheimer's. A specific TNFR2 agonist may prevent cell death, offering a new treatment direction.
Researchers at Tel Aviv University have discovered that structural instabilities in the myelin sheaths of neurons may enable the immune system to launch an uncontrolled attack on them, leading to multiple sclerosis. The study suggests a potential trigger for the disease's outbreak and offers new avenues for therapies and diagnostics.
A recent study at Mayo Clinic and other academic medical centers identified common conditions mistaken for multiple sclerosis, revealing potential risks of misdiagnosis. The research highlights the need for better clinician education on using diagnostic criteria to avoid premature or incorrect MS diagnoses.
A study by researchers at four US medical centers found that common conditions are frequently misdiagnosed as multiple sclerosis, leading patients to receive unnecessary treatment. The study identified five primary diagnoses that mimic MS symptoms, resulting in long-term misdiagnosis for some patients.
A clinical trial at the University of Iowa will compare the effects of two popular diets on multiple sclerosis-related fatigue. The 36-week trial will recruit 100 people with relapsing-remitting MS and follow their health for 24 weeks, monitoring their health and activities.
Researchers have developed a cost-effective method using the Microsoft Kinect to evaluate gait abnormalities in multiple sclerosis patients. The device detects movement and computer algorithms quantify walking patterns, reducing human error. The technology shows promise for diagnosing gait pathology and tracking treatment effects.
A long-term study found that starting medication for multiple sclerosis at the earliest sign of the disease can prolong the time before a definitive diagnosis is made. Participants who received early treatment had 33% fewer diagnoses of MS, more time between relapses, and lower yearly relapse rates compared to those on delayed treatment.
Researchers developed an antibody that prevents the immune system from attacking the myelin sheath, reducing demyelination and axon degeneration. In experimental mouse models, treatment with the antibody blocked progression of motor disorders and reduced lymphocyte infiltration into the nervous tissue.
The National Stem Cell Foundation has funded a grant to study how astrocytes can be manipulated to halt or prevent neurodegeneration in diseases like MS and Parkinson's. The researchers aim to advance understanding of cell cross-talk in the central nervous system.
Researchers at Brigham and Women's Hospital found altered gut microorganisms in patients with multiple sclerosis, including those treated with therapy. These changes correlated with immune system gene activity and breath methane levels. The study supports the connection between gut microbiome and immunological disorders like MS.
Researchers have found fecal transplants to be effective in treating certain infections and diseases, including C. difficile colitis with a 95% cure rate. The transplantation of stool from healthy individuals also shows promise in treating multiple sclerosis and Crohn's disease.
A new study in Biological Psychiatry reveals that inflammation of the hippocampus contributes to depressive symptoms in multiple sclerosis patients. Hippocampal immune activation was linked to more severe symptoms of depression and altered functional connections with other brain regions.
Researchers at Aarhus University discovered how simvastatin reduces inflammation in chronic diseases like rheumatoid arthritis and multiple sclerosis. The study found that simvastatin acts as a 'plug' in proteins retaining immune cells, reducing inflammation and improving symptoms.
A comprehensive review article examines the role of gut bacteria and viruses in MS development and progression. Alterations in gut microbiome composition may influence immune system activity and autoimmune disorders like MS.
A new study published in PLOS Medicine found that obesity in early adulthood is associated with a significantly increased risk of developing multiple sclerosis. The research, led by Dr. Brent Richards, used Mendelian randomization to investigate the link between genetically determined obesity and MS risk. The study found that an averag...
A recent study published in Scientific Reports found a distinct gut microbiome in multiple sclerosis patients compared to healthy individuals. The research suggests that patients with MS have reduced levels of beneficial bacteria, which are associated with overall health benefits.
Scientists identified four new risk genes linked to epigenetic mechanisms in MS, which affect gene regulation within immune cells. These findings suggest that environmental influences play a significant role in the development of MS, with epigenetic signals marking DNA sequences and regulating gene activation.
Researchers found that cerebral microbleeds are associated with increased physical and cognitive disability in multiple sclerosis (MS) patients. The study suggests that monitoring MS patients with cerebral microbleeds could be crucial in preventing further decline.
Researchers found that genetic variants of the S1P1 receptor influence fingolimod's effectiveness in treating multiple sclerosis. The study used mouse models to demonstrate that an S1PR1 variant affecting phosphorylation ability led to reduced fingolimod efficacy, and treatment with a CCR6-blocking antibody delayed disease progression.
A recent review by University of Alberta researchers found little evidence to support the benefits of vitamin D supplementation for various health conditions. Strongest effects were seen in reducing falls and fractures among the elderly. Moderate supplementation is unlikely to cause harm but will not lead to significant health benefits.
A University of Michigan study found an association between obstructive sleep apnea and cognitive dysfunction in MS patients. Treating OSA with CPAP therapy may help improve cognitive function in these patients.
Researchers developed PET tracers that can visualize inflammatory disease and evaluate next-generation MS therapies. The study found that the compounds could detect an increase in S1P1 expression in animals with an inflammatory response, suggesting a promising approach for imaging MS and other inflammatory diseases.
Researchers at Karolinska Institutet identified 12 subclasses of oligodendrocytes and a novel cell distinct from oligodendrocytes residing in blood vessels, uncovering unexpected diversity within the nerve-insulating cells.
A clinical trial shows that an intensive procedure replacing the diseased immune system with a new one using blood stem cells can eliminate all signs of brain inflammation in people with early, aggressive multiple sclerosis. The treatment resulted in zero clinical relapses and no new active inflammatory lesions over 4-13 year follow-up.
A new treatment uses chemotherapy followed by autologous haematopoietic stem cell transplantation to fully halt clinical relapses and development of new brain lesions in patients with multiple sclerosis. Eight patients showed a sustained improvement in disability 7.5 years after treatment.
Lawrence Steinman, MD, receives the fifth Anthony Cerami Award in Translational Medicine for his pioneering work on multiple sclerosis. His monograph explores translational research and teamwork in achieving medical breakthroughs.
Researchers have identified a gene mutation that can directly cause the development of multiple sclerosis, a neurodegenerative disease affecting 2 million worldwide. The mutation in NR1H3 gene leads to loss of function of its protein product LXRA, controlling lipid homeostasis and inflammation.
Scientists have discovered a single genetic mutation that causes multiple sclerosis in two-thirds of those affected, providing a potential target for therapies. The mutation leads to a defective protein that disrupts communication between the brain and body, resulting in vision problems, muscle weakness, and cognitive impairments.
A new gene, ANKRD55, has been discovered to play a significant role in the neuro-inflammation process of Multiple Sclerosis. The study found that genetic variants associated with MS increase the production of ANKRD55 transcripts in immune cells, suggesting a key gene involved in deregulation.
A new study suggests that a fasting-like diet can reduce symptoms of multiple sclerosis by triggering a death-and-life process for cells, which appears critical for the body's repair. The diet promotes regeneration of myelin, the sheath of proteins and fats that insulate nerve fibers, and improves immune function.
Research suggests that people who take foreign breaks have higher levels of vitamin D in their blood, which has been linked to wide-ranging health benefits. Farmers also have higher levels of vitamin D, particularly those over 60 years old.
A recent study reveals differences in gut bacteria between children with and without multiple sclerosis. Key findings include an association between MS and increased inflammatory bacteria, as well as decreased anti-inflammatory bacteria. The discovery may pave the way for new therapeutic approaches by identifying novel drug targets.
A new study links MS drug mitoxantrone to an increased risk of colorectal cancer, with patients treated with the medication being three times more likely to develop the disease. However, the overall rate of cancer was low enough that the researchers suggest continuing its use for severely affected patients.
Researchers at Brigham and Women's Hospital found that dietary tryptophan can limit brain inflammation in a mouse model of multiple sclerosis. In human patients, decreased levels of these molecules were observed, hinting at a possible link between gut flora and neurodegeneration.
Researchers found that yoga and aquatic exercise significantly improved symptoms of multiple sclerosis, including reduced fatigue, depression, and paresthesia. The study, involving 54 women with MS, showed a significant reduction in moderate to severe depression in those who exercised three times a week.
In a study, MS patients showed more severe moral judgments than average, even in neutral conditions, attributing negative emotions to external causes. This 'externally oriented thinking' helps them minimize damage but also leads to an inability to reflect on emotions and identify real causes of their negative emotional state.
Researchers at the Center for BrainHealth will investigate how changes in brain blood flow affect cognition in individuals with multiple sclerosis (MS). They will use fMRI to examine cerebral blood flow and neural metabolic rate, aiming to pinpoint the brain systems responsible for cognitive slowing in MS.
A new study found rituximab more effective in preventing relapses among patients with highly active multiple sclerosis switching from natalizumab. Patients infected with JC virus showed a significant reduction in clinical relapse risk after treatment switch to rituximab.
A new study found that at-home cognitive remediation training using a computer program can significantly improve cognitive test scores in people with multiple sclerosis. Participants who used the program for 12 weeks showed a 29% improvement, compared to a 15% improvement in the placebo group.
A preliminary study found that clemastine fumarate partially reversed optic nerve damage in people with MS. The drug improved transmission signal times by an average of 2 milliseconds per patient, suggesting possible myelin repair.
Researchers at University of Queensland have developed a new plant-derived drug, T20K, that can block the progression of multiple sclerosis. The treatment, extracted from the Oldenlandia affinis plant, has shown success in an animal model and may offer a new quality of life for people with the debilitating disease.
A small study suggests Zika virus may be associated with an autoimmune disorder attacking the brain's myelin, similar to multiple sclerosis. Researchers found six people developed neurologic symptoms consistent with autoimmune disorders and underwent exams and blood tests, revealing signs of damage to the brain's white matter.
A study in east London found higher MS prevalence among Black people and South Asians compared to their ancestral countries, suggesting an increased environmental influence on the disease. The researchers propose that exposure to environmental agents or behaviors may facilitate MS development.